Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Shuangxing Pharmaceutical is a Chinese pharmaceutical company based in Dangyang, Hubei Province, specializing in the research, development, and large-scale manufacturing of chemical APIs and finished drug products. The company's portfolio primarily focuses on anti-infectives, including nitroimidazoles and fluoroquinolones, as well as treatments for cardiovascular and gastrointestinal conditions. With multiple GMP-certified production lines, it serves both domestic and international markets with a range of essential generic medications. Hubei Shuangxing is particularly recognized for its production capacity of widely used agents such as metronidazole, tinidazole, and various quinolone antibiotics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Shuangxing Pharmaceutical.